Cargando…

Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones

BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Velázquez-Vázquez, María Guadalupe, Alberti-Minutti, Paolo, Campos-Aguirre, Esmeralda, Benítez-Arvizu, Gamaliel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395998/
https://www.ncbi.nlm.nih.gov/pubmed/36378067
_version_ 1785083705789775872
author Velázquez-Vázquez, María Guadalupe
Alberti-Minutti, Paolo
Campos-Aguirre, Esmeralda
Benítez-Arvizu, Gamaliel
author_facet Velázquez-Vázquez, María Guadalupe
Alberti-Minutti, Paolo
Campos-Aguirre, Esmeralda
Benítez-Arvizu, Gamaliel
author_sort Velázquez-Vázquez, María Guadalupe
collection PubMed
description BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and the associated factors in MR of a third level hospital. MATERIAL AND METHODS: 330 MR from different specialties were evaluated with a questionnaire and collection of blood samples for analysis by microparticle chemiluminescent immunoassay. The prevalence of previous infection was defined by seropositivity of these antibodies. Descriptive statistics and concordance between the RT-PCR tests and the presence of anti-SARS-CoV-2 IgG were used. RESULTS: Of 330 MR, 84.5% actively participated in COVID patient care. One out of 3 reported symptoms of COVID-19; in 67.6% the possible site of infection was a hospital setting not associated with the COVID area. Out of 71 symptomatic subjects, 61.9% underwent RT-PCR against SARS-CoV-2; 20 were positive. In 15.8% of the total, the presence of anti-SARS-CoV-2 IgG antibodies was determined. Only 1 out of 3 subjects with a positive PCR had antibodies, and 11.3% of the cases, even with a positive RT-PCR test, did not develop humoral immunity. CONCLUSIONS: The seroprevalence was lower than that reported at the national level, potentially due to protection measures. The main risk factor was contact with the virus in areas of the hospital not related to COVID, making it imperative to reinforce security protocols in those spaces.
format Online
Article
Text
id pubmed-10395998
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Instituto Mexicano del Seguro Social
record_format MEDLINE/PubMed
spelling pubmed-103959982023-08-04 Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones Velázquez-Vázquez, María Guadalupe Alberti-Minutti, Paolo Campos-Aguirre, Esmeralda Benítez-Arvizu, Gamaliel Rev Med Inst Mex Seguro Soc Aportación Original BACKGROUND: COVID-19 pandemic spread around the world swiftly; there are several diagnostic strategies available. Health workers, especially medical residents (MR), are a high-risk population for acquiring this infection. OBJECTIVE: To estimate the seroprevalence of antibodies against SARS-CoV-2 and the associated factors in MR of a third level hospital. MATERIAL AND METHODS: 330 MR from different specialties were evaluated with a questionnaire and collection of blood samples for analysis by microparticle chemiluminescent immunoassay. The prevalence of previous infection was defined by seropositivity of these antibodies. Descriptive statistics and concordance between the RT-PCR tests and the presence of anti-SARS-CoV-2 IgG were used. RESULTS: Of 330 MR, 84.5% actively participated in COVID patient care. One out of 3 reported symptoms of COVID-19; in 67.6% the possible site of infection was a hospital setting not associated with the COVID area. Out of 71 symptomatic subjects, 61.9% underwent RT-PCR against SARS-CoV-2; 20 were positive. In 15.8% of the total, the presence of anti-SARS-CoV-2 IgG antibodies was determined. Only 1 out of 3 subjects with a positive PCR had antibodies, and 11.3% of the cases, even with a positive RT-PCR test, did not develop humoral immunity. CONCLUSIONS: The seroprevalence was lower than that reported at the national level, potentially due to protection measures. The main risk factor was contact with the virus in areas of the hospital not related to COVID, making it imperative to reinforce security protocols in those spaces. Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10395998/ /pubmed/36378067 Text en © 2023 Revista Medica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional.
spellingShingle Aportación Original
Velázquez-Vázquez, María Guadalupe
Alberti-Minutti, Paolo
Campos-Aguirre, Esmeralda
Benítez-Arvizu, Gamaliel
Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title_full Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title_fullStr Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title_full_unstemmed Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title_short Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
title_sort incompatibilidad abo en el trasplante de células progenitoras hematopoyéticas y sus complicaciones
topic Aportación Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395998/
https://www.ncbi.nlm.nih.gov/pubmed/36378067
work_keys_str_mv AT velazquezvazquezmariaguadalupe incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones
AT albertiminuttipaolo incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones
AT camposaguirreesmeralda incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones
AT benitezarvizugamaliel incompatibilidadaboeneltrasplantedecelulasprogenitorashematopoyeticasysuscomplicaciones